A Phase I/II multi-centre clinical trial, called B-AMAZE, has found that a single gene therapy injection dramatically reduces the bleeding risk faced by people living with haemophilia B and enabled trial participants to stop their regular blood clotting factor replacement therapy. The study is published in the July 21, 2022 issue of the New England […]
Cambridgeshire, UK-based Paragraf, the first company in the world to deliver a scalable approach to graphene electronic device manufacturing, has announced a plan to develop a new generation of graphene-based, in-vitro diagnostic products that will give results within a few minutes. With the support of a £550,000 Biomedical Catalyst grant award from Innovate UK, […]
The MENA DIGIHEALTH forum will bring together thought leaders from healthcare sector. These leaders will be from both public and private healthcare entities which includes health ministries, private healthcare institutions, digital health experts, researchers and government bodies to share their knowledge and highlight the need for digital health in challenging times. The main objective is […]
LifeArc and the UK Dementia Research Institute (UK DRI) have launched a new partnership to accelerate development of new diagnostic tests, treatments, and devices from scientific research discoveries to benefit people with dementia. Around 900,000 people in the UK are living with dementia.
It is known that the nervous system communicates with the immune system and can regulate inflammation in the body. Now scientists at Karolinska Institutet in Sweden have shown how electrical activation of a specific nerve can promote healing in acute inflammation. The finding, which is published in the journal PNAS, opens new ways to accelerate […]
A team of researchers co-led by University of California San Francisco’s Allan Balmain, PhD, FRS, has been selected to receive a $25 million Cancer Grand Challenges award to investigate the very early stages of cancer development. Cancer Grand Challenges is a global funding platform, co-founded by Cancer Research UK (CRUK) and the National Cancer Institute […]
Emergency Preservation and Resuscitation (EPR), rapid profound hypothermia, is being pursued in clinical trials, as a revolutionary approach to be the next standard of emergency care to save lives when cardiopulmonary resuscitation (CPR) fails.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
